NO20032183L - Histon-deacetylase-inhibitor og anvendelse derav - Google Patents

Histon-deacetylase-inhibitor og anvendelse derav

Info

Publication number
NO20032183L
NO20032183L NO20032183A NO20032183A NO20032183L NO 20032183 L NO20032183 L NO 20032183L NO 20032183 A NO20032183 A NO 20032183A NO 20032183 A NO20032183 A NO 20032183A NO 20032183 L NO20032183 L NO 20032183L
Authority
NO
Norway
Prior art keywords
histone deacetylase
deacetylase inhibitor
inhibitor
histone
deacetylase
Prior art date
Application number
NO20032183A
Other languages
English (en)
Other versions
NO20032183D0 (no
Inventor
Osamu Nakanishi
Takayuki Tatamiya
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of NO20032183D0 publication Critical patent/NO20032183D0/no
Publication of NO20032183L publication Critical patent/NO20032183L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4703—Regulators; Modulating activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
NO20032183A 2002-05-15 2003-05-14 Histon-deacetylase-inhibitor og anvendelse derav NO20032183L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2002140586 2002-05-15

Publications (2)

Publication Number Publication Date
NO20032183D0 NO20032183D0 (no) 2003-05-14
NO20032183L true NO20032183L (no) 2003-11-17

Family

ID=19194554

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20032183A NO20032183L (no) 2002-05-15 2003-05-14 Histon-deacetylase-inhibitor og anvendelse derav

Country Status (3)

Country Link
US (2) US20030216345A1 (no)
EP (1) EP1362914A3 (no)
NO (1) NO20032183L (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6777217B1 (en) * 1996-03-26 2004-08-17 President And Fellows Of Harvard College Histone deacetylases, and uses related thereto
US20030129724A1 (en) 2000-03-03 2003-07-10 Grozinger Christina M. Class II human histone deacetylases, and uses related thereto
NO20032183L (no) * 2002-05-15 2003-11-17 Schering Ag Histon-deacetylase-inhibitor og anvendelse derav
US7154002B1 (en) 2002-10-08 2006-12-26 Takeda San Diego, Inc. Histone deacetylase inhibitors
US7250514B1 (en) 2002-10-21 2007-07-31 Takeda San Diego, Inc. Histone deacetylase inhibitors
KR20050122210A (ko) 2003-03-17 2005-12-28 다케다 샌디에고, 인코포레이티드 히스톤 탈아세틸화 효소 억제제
ES2239529B1 (es) * 2004-01-20 2006-10-01 Universidad Autonoma De Madrid Procedimiento de identificacion de los compuestos reguladores de la actividad tubulina desacetilasa de hdac6 y sus aplicaciones.
JP2008524246A (ja) 2004-12-16 2008-07-10 タケダ サン ディエゴ インコーポレイテッド ヒストンデアセチラーゼ阻害剤
US8999289B2 (en) 2005-03-22 2015-04-07 President And Fellows Of Harvard College Treatment of protein degradation disorders
WO2006122319A2 (en) 2005-05-11 2006-11-16 Takeda San Diego, Inc. Histone deacetylase inhibitors
ZA200800901B (en) 2005-07-14 2010-05-26 Takeda San Diego Inc Histone deacetylase inhibitors
US8222423B2 (en) 2006-02-14 2012-07-17 Dana-Farber Cancer Institute, Inc. Bifunctional histone deacetylase inhibitors
AU2007248656B2 (en) * 2006-05-03 2013-04-04 Dana-Farber Cancer Institute, Inc. Histone deacetylase and tubulin deacetylase inhibitors
US8293513B2 (en) * 2007-12-14 2012-10-23 Georgetown University Histone deacetylase inhibitors
US8440716B2 (en) 2008-07-23 2013-05-14 President And Fellows Of Harvard College Deacetylase inhibitors and uses thereof
EP2344889A2 (en) * 2008-10-14 2011-07-20 Oregon Health and Science University Methods for the selection of therapeutic treatments for cancer
US8716344B2 (en) 2009-08-11 2014-05-06 President And Fellows Of Harvard College Class- and isoform-specific HDAC inhibitors and uses thereof
WO2014085471A1 (en) * 2012-11-28 2014-06-05 Prognosdx Health, Inc. Acid-activated compositions for the treatment of cancers, methods of their use and methods of their preparation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5998148A (en) * 1999-04-08 1999-12-07 Isis Pharmaceuticals Inc. Antisense modulation of microtubule-associated protein 4 expression
EP1438404A2 (en) * 2000-03-24 2004-07-21 Methylgene, Inc. Inhibition of specific histone deacetylase isoforms
US20020137162A1 (en) * 2000-03-24 2002-09-26 Zuomei Li Antisense oligonucleotide inhibition of specific histone deacetylase isoforms
AU2001248701A1 (en) * 2000-03-24 2001-10-03 Methylgene, Inc. Inhibitors of histone deacetylase
CA2403946A1 (en) * 2000-04-05 2001-10-18 Incyte Genomics, Inc. Genes expressed in foam cell differentiation
NO20032183L (no) * 2002-05-15 2003-11-17 Schering Ag Histon-deacetylase-inhibitor og anvendelse derav

Also Published As

Publication number Publication date
EP1362914A3 (en) 2004-05-06
US20080213813A1 (en) 2008-09-04
NO20032183D0 (no) 2003-05-14
US20030216345A1 (en) 2003-11-20
EP1362914A2 (en) 2003-11-19

Similar Documents

Publication Publication Date Title
ATE473005T1 (de) Histone-deacetylase-inhibitoren
ATE354366T1 (de) Histondeacetylase-hemmer
DK1495002T3 (da) Benzamide derivatives useful as histone deacetylase inhibitors
AU2003286249A8 (en) Histone deacetylase inhibitors
NO20032183D0 (no) Histon-deacetylase inhibitor og anvendelse derav
IS6934A (is) Nýjar spírótrísýklískar afleiður og notkun þeirrasem fosfódíesterasa-7-hindrar
DK1592686T3 (da) Gyrase-inhibitorer og anvendelser deraf
DK1648426T3 (da) Benzimidazolderivater og anvendelse heraf som proteinkinaseinhibitorer
IS7434A (is) N-amínóasetýl-pýrrólídín-2-karbónítríl og notkun þeirra sem DDP-IV tálma
EP1789381A4 (en) INHIBITORS OF HISTONE DEACETYLASE
ATE395343T1 (de) Sulfonylderivate als histone-deacetylase- inhibitoren
NO20055417D0 (no) Farmasoytisk blanding inneholdene histon-deacetylaseinhibitor
NO20052524D0 (no) Aminerte isofiavonoidderivater og anvendelse derav
AU2003219595A8 (en) Alpha,beta-unsaturated hydroxamic acid derivatives and their use as histone deacetylase inhibitors
NO20041872L (no) Esterforbindelser og medisinsk anvendelse derav
IS2504B (is) Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
IS7594A (is) Laxófoxifen tafla og húðun hennar
EP1507541A4 (en) HEMMER AND APPLICATION METHOD THEREFOR
PT1558595E (pt) Piperazinil e diazepanil benzamidas e benzotioamidas
ITMI20021399A0 (it) Inibitori della cicloossigenasi 2
EP1771167A4 (en) Histone deacetylase INHIBITORS:
EP1408946A4 (en) HISTONE DEACETYLASE INHIBITORS
NO20055668D0 (no) Beta-amyloidinhibitorer og anvendelse derav
TWI346661B (en) Inhibitors of histone deacetylase
DK1301184T3 (da) Valproinsyre og derivater deraf som histondeacetylaseinhibitorer

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application